A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer's progression.
The brain has its own built-in immune system that identifies threats and responds to them. In Alzheimer's disease, growing evidence shows that this system becomes persistently overactive. The result is chronic inflammation that damages the connections between brain cells.
In a preclinical study using human Alzheimer's brain cells, scientists at Scripps Research have identified a molecular trigger behind this process. The finding points to a potential drug target that could help control harmful inflammation.
A Molecular Switch Behind Inflammation
The study, published in Cell Chemical Biology, focuses on a protein called STING. Under normal conditions, STING acts as part of the immune system's early warning network. In Alzheimer's brains, however, researchers found that STING undergoes a chemical change called S-nitrosylation (or SNO, a reaction involving sulfur, oxygen and nitrogen). This modification drives the protein into an overactive state. When scientists blocked this change in a mouse model, brain inflammation was reduced.
"This is a new and important therapeutic target for Alzheimer's disease," says senior author Stuart Lipton, the Step Family Foundation Endowed Chair at Scripps Research and a clinical neurologist. "It's exciting to see that blocking this switch in mice reduces inflammation and protects the very brain cell connections that are lost in Alzheimer's, especially because we found the same pathway to be activated in human Alzheimer's brain samples and in human stem cell-derived models."
More than 30 years ago, Lipton, who also co-directs the Neurodegeneration New Medicines Center at Scripps Research, first described S-nitrosylation. In this process, a molecule related to nitric oxide (NO) attaches to a cysteine amino acid in proteins, forming "SNO" and altering how the protein behaves.
His lab later showed that SNO can be triggered by aging, inflammation, and environmental exposures such as air pollution and wildfire smoke. These changes can disrupt many proteins throughout the body. This widespread effect, referred to as a "SNO-STORM," has been linked to diseases including cancer, Parkinson's disease, and Alzheimer's.
Pinpointing STING's Weak Spot
In the new study, researchers took a closer look at STING, which had already been associated with Alzheimer's-related inflammation. Lipton's team, led by postdoctoral researcher Lauren Carnevale, worked with Professor John Yates III, a mass spectrometry expert at Scripps Research and holder of the John Lytton Young Endowed Chair.
They identified the exact location where S-nitrosylation occurs on STING, focusing on a single amino acid known as cysteine 148. When this site is modified, STING forms clusters and sets off inflammatory signaling.
Elevated levels of this altered form, called SNO-STING, were detected in postmortem brain tissue from Alzheimer's patients, in lab-grown human brain immune cells exposed to Alzheimer's proteins, and in mice with the disease.
Further experiments revealed that hallmark Alzheimer's protein clumps, including amyloid-beta and alpha-synuclein, can directly trigger S-nitrosylation of STING. This suggests a feedback loop. Protein buildup, along with aging and environmental stress, may spark inflammation that produces nitric oxide. That, in turn, modifies STING and amplifies inflammation even further.
Protecting Brain Connections
To test this mechanism, the team created a version of STING that lacks cysteine 148, preventing the S-nitrosylation step. When introduced into a mouse model of Alzheimer's, this modified protein significantly reduced inflammation in brain immune cells.
Importantly, it also preserved synapses, the connections between nerve cells that are essential for memory and thinking. Loss of synapses is closely linked to cognitive decline in dementia, so protecting them is a key goal in Alzheimer's research.
"What makes this target particularly promising is that we can quiet the pathological overactivation of STING without shutting down the normal immune response," says Lipton. "You still need STING to protect yourself from infections, and when we target cysteine 148, we're not blocking the entire molecule; we're just preventing STING from becoming overactivated."
Lipton's team is now developing small molecules designed to block cysteine 148, with plans to test them in future preclinical studies.
Reference: "Redox regulation of neuroinflammatory pathways contributes to damage in Alzheimer's disease brain" by Lauren N. Carnevale, Piu Banerjee, Xu Zhang, Jazmin Navarro, Charlene K Raspur, Parth Patel, Tomohiro Nakamura, Emily Schahrer, Henry Scott, Nhi Lang, Jolene K. Diedrich, Amanda J. Roberts, John R. Yates and Stuart A. Lipton, 23 April 2026, Cell Chemical Biology.
DOI: 10.1016/j.chembiol.2026.03.017
This work was supported in part by the National Institutes of Health (R35 AG071734, U01 AG088679, RF1 AG057409, R01 AG078756, R01 AG056259, R01 DA048882, DP1 DA041722 and R01 AG077046), and the U.S. Department of Defense/U.S. Department of the Army (AR230101).
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Your immune system is supposed to clear out damaged cells. Researchers may have found how some of them hide and linger as the body ages. Researchers led by Cedars-Sinai Health Sciences University have identified [...]
